You are here

P&T News

April 17

Cancer specialists examine future payment models to improve care and lower costs
Sandoz makes a move on Teva’s immune modifier
Median progression-free survival is 13.5 months for AZD9291
Pivotal phase III data to be presented at neurology meeting
Nurse-led innovations save more than $28 million annually nationwide, association says

April 16

Treatment indicated to reduce risk of hospitalization
Risk is dose-dependent for simvastatin and atorvastatin
Specialty societies give ‘thumbs down’ to low-benefit, high-cost preoperative testing
But some Medicare doctors still face temporary pay cuts
Centers judged on patients' satisfaction

April 15

Last-minute vote avoids 21% pay cut for Medicare doctors
Method is ‘better than mammography,’ researcher says
Breast cancer drug improves progression-free survival

April 14

IMS report notes high cost of new hepatitis C drugs
Committee’s conclusions called ‘fallacious’
Results can be displayed on smartphone app or PC
Critics of ‘doc fix’ initiative attack cost, amendments

Pages